Beam Therapeutics Inc.

Historical 13F Holders

Symbol: BEAM
CUSIP: 07373V105
All holders as of: Q2 2026
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 07373V105 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
FMR LLC 13G/A	12.6%	12,750,369.42	13G/A	2/5/2026 Event 12/31/2025
FMR LLC	12.6%	12,750,369.42
Abigail P. Johnson	12.6%	12,750,369.42
Farallon Capital Management, L.L.C. 13G/A	10.0%	10,282,210	13G/A	8/13/2026 Event 6/30/2026
Farallon Capital Management, L.L.C.	10.0%	10,282,210
Farallon Capital Partners, L.P.	0%	0
Farallon Capital Institutional Partners, L.P.	0%	0
Farallon Capital Institutional Partners II, L.P.	0%	0
Farallon Capital Institutional Partners III, L.P.	0%	0
Four Crossings Institutional Partners V, L.P.	0%	0
Farallon Capital Offshore Investors II, L.P.	0%	0
Farallon Capital (AM) Investors, L.P.	0%	0
Farallon Capital F5 Master I, L.P.	0%	0
Farallon Healthcare Partners Master, L.P.	0%	0
Farallon Partners, L.L.C.	0%	0
Farallon Institutional (GP) V, L.L.C.	0%	0
Farallon F5 (GP), L.L.C.	0%	0
Farallon Healthcare Partners (GP), L.L.C.	0%	0
Dapice Joshua J.	10.0%	10,282,210
Dreyfuss, Philip D.	10.0%	10,282,210
Dunn Hannah E.	10.0%	10,282,210
Gehani, Varun N.	10.0%	10,282,210
Giauque, Nicolas	10.0%	10,282,210
Husen, Avner A.	10.0%	10,282,210
Kim, David T.	10.0%	10,282,210
Linn, Michael G.	10.0%	10,282,210
Luo Patrick (Cheng)	10.0%	10,282,210
Roberts, Jr., Thomas G.	10.0%	10,282,210
Saito Edric C.	10.0%	10,282,210
Short Daniel S.	10.0%	10,282,210
Spokes, Andrew J. M.	10.0%	10,282,210
Warren, John R.	10.0%	10,282,210
Wehrly, Mark C.	10.0%	10,282,210
Farallon Capital Partners, L.P. 13G/A	10.0%	10,141,856	13G/A	2/5/2026 Event 12/31/2025
Farallon Capital Partners, L.P.	0.7%	688,623
Farallon Capital Institutional Partners, L.P.	0.8%	836,691
Farallon Capital Institutional Partners II, L.P.	0.2%	233,233
Farallon Capital Institutional Partners III, L.P.	0.1%	104,266
Four Crossings Institutional Partners V, L.P.	0.1%	150,101
Farallon Capital Offshore Investors II, L.P.	1.6%	1,632,718
Farallon Capital (AM) Investors, L.P.	0.1%	94,237
Farallon Capital F5 Master I, L.P.	0.3%	333,253
Farallon Healthcare Partners Master, L.P.	6.0%	6,068,735
Farallon Partners, L.L.C.	9.7%	9,808,603
Farallon Institutional (GP) V, L.L.C.	0.1%	150,101
Farallon F5 (GP), L.L.C.	0.3%	333,253
Farallon Healthcare Partners (GP), L.L.C.	6.0%	6,068,735
Dapice Joshua J.	10.0%	10,141,856
Dreyfuss, Philip D.	10.0%	10,141,856
Dunn Hannah E.	10.0%	10,141,856
Fried, Richard B	0%	0
Gehani, Varun N.	10.0%	10,141,856
Giauque, Nicolas	10.0%	10,141,856
Husen, Avner A.	10.0%	10,141,856
Kim, David T.	10.0%	10,141,856
Linn, Michael G.	10.0%	10,141,856
Luo Patrick (Cheng)	10.0%	10,141,856
Patel, Rajiv A.	0%	0
Roberts, Jr., Thomas G.	10.0%	10,141,856
Saito Edric C.	10.0%	10,141,856
Seybold, William	0%	0
Short Daniel S.	10.0%	10,141,856
Spokes, Andrew J. M.	10.0%	10,141,856
Warren, John R.	10.0%	10,141,856
Wehrly, Mark C.	10.0%	10,141,856
ARK Investment Management LLC 13G/A	10.0%	10,234,862	13G/A	8/14/2026 Event 6/30/2026
ARK Investment Management LLC	10.0%	10,234,862
Catherine D. Wood	10.0%	10,234,862
BlackRock, Inc. 13G/A	7.5%	7,499,930	13G/A	4/17/2025 Event 3/31/2025
State Street Corp 13G	5.2%	5,228,529	13G	2/9/2026 Event 12/31/2025
Vanguard Capital Management LLC 13G	5.0%	5,122,475	13G	4/29/2026 Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
ARCH Venture Fund IX, L.P. 13G/A	4.6%	4,600,747	13G/A	5/15/2025 Event 3/31/2025
ARCH Venture Fund IX, L.P.	4.5%	4,540,132
ARCH Venture Fund IX Overage, L.P.	4.5%	4,540,132
ARCH Venture Partners IX, L.P.	4.5%	4,540,132
ARCH Venture Partners IX Overage, L.P.	4.5%	4,540,132
ARCH Venture Partners IX, LLC	4.5%	4,540,132
Keith Crandell	4.5%	4,557,862
Clinton Bybee	4.5%	4,550,630
Robert Nelsen	4.6%	4,600,747
Vanguard Group Inc 13G/A	0%	0	13G/A	3/26/2026 Event 3/13/2026

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	9	23.2 k	$566 k	$0
2026 Q2	287	113 M	$4.20 B	$26.9 M
2026 Q1	266	108 M	$2.58 B	$21.1 M
2025 Q4	261	107 M	$2.96 B	$73.2 M
2025 Q3	239	107 M	$2.60 B	$37.6 M
2025 Q2	239	109 M	$1.85 B	$47.0 M
2025 Q1	248	101 M	$1.99 B	$14.3 M
2024 Q4	243	81.5 M	$2.02 B	$9.38 M
2024 Q3	234	79.7 M	$1.95 B	$16.4 M
2024 Q2	229	79.1 M	$1.85 B	$11.4 M
2024 Q1	243	79.1 M	$2.61 B	$35.9 M
2023 Q4	203	74.1 M	$2.02 B	$13.2 M
2023 Q3	208	67.4 M	$1.62 B	$17.1 M
2023 Q2	210	64.2 M	$2.05 B	$19.3 M
2023 Q1	225	60.4 M	$1.85 B	$25.3 M
2022 Q4	228	59.0 M	$2.31 B	$22.5 M
2022 Q3	243	54.7 M	$2.60 B	$46.2 M
2022 Q2	213	54.8 M	$2.09 B	$19.0 M
2022 Q1	254	49.2 M	$2.82 B	$41.0 M
2021 Q4	246	45.6 M	$3.64 B	$49.8 M
2021 Q3	241	45.2 M	$3.93 B	$42.5 M
2021 Q2	253	46.2 M	$5.93 B	$86.4 M
2021 Q1	233	43.6 M	$3.47 B	$109 M
2020 Q4	171	37.0 M	$3.02 B	$56.9 M
2020 Q3	86	29.5 M	$727 M	$0
2020 Q2	72	27.7 M	$776 M	$0
2020 Q1	62	27.2 M	$489 M	$0